TY - JOUR
T1 - The patient journey
T2 - A report of skin cancer care across Europe
AU - Trakatelli, M.
AU - Siskou, S.
AU - Proby, C.
AU - Tiplica, G. S.
AU - Hinrichs, B.
AU - Altsitsiadis, E.
AU - Kitsou, A.
AU - Ferrandiz, L.
AU - Aquilina, S.
AU - Apap, C.
AU - Ulrich, M.
AU - Fiorentini, C.
AU - Magnoni, C.
AU - De Vries, E.
AU - Flohil, S. C.
AU - Kalokasidis, K.
AU - Moreno-Ramirez, D.
AU - Ruiz-De-Casas, A.
AU - Majewski, S.
AU - Ranki, A.
AU - Pitkänen, S.
AU - Saksela, O.
AU - Ioannides, D.
AU - Sotiriadis, D.
AU - Stockfleth, E.
PY - 2012/8
Y1 - 2012/8
N2 - Summary Background There are poorly documented variations in the journey a skin cancer patient will follow from diagnosis to treatment in the European Union. Objectives To investigate the possible difficulties or obstacles that a person with a skin malignancy in the European Union may have to overcome in order to receive adequate medical screening and care for his/her condition. In addition, we wished to explore differences in European health systems, which may lead to health inequalities and health inequities within Europe. Methods Ten European countries took part in this investigation (in alphabetical order): Finland, Germany, Greece, Italy, Malta, Poland, Romania, Spain, the Netherlands and the U.K. The individual participants undertook local and national enquiries within their own country and completed a questionnaire. Results This exercise has identified important differences in the management of a skin cancer patient, reflecting major disparities in health care between European countries. Conclusions Further investigation of health disparities and efforts to address health inequalities should lead to improvements in European health care quality and reduction in morbidity from skin cancer.
AB - Summary Background There are poorly documented variations in the journey a skin cancer patient will follow from diagnosis to treatment in the European Union. Objectives To investigate the possible difficulties or obstacles that a person with a skin malignancy in the European Union may have to overcome in order to receive adequate medical screening and care for his/her condition. In addition, we wished to explore differences in European health systems, which may lead to health inequalities and health inequities within Europe. Methods Ten European countries took part in this investigation (in alphabetical order): Finland, Germany, Greece, Italy, Malta, Poland, Romania, Spain, the Netherlands and the U.K. The individual participants undertook local and national enquiries within their own country and completed a questionnaire. Results This exercise has identified important differences in the management of a skin cancer patient, reflecting major disparities in health care between European countries. Conclusions Further investigation of health disparities and efforts to address health inequalities should lead to improvements in European health care quality and reduction in morbidity from skin cancer.
UR - http://www.scopus.com/inward/record.url?scp=84865039768&partnerID=8YFLogxK
U2 - 10.1111/j.1365-2133.2012.11086.x
DO - 10.1111/j.1365-2133.2012.11086.x
M3 - Article
C2 - 22881587
AN - SCOPUS:84865039768
SN - 0007-0963
VL - 167
SP - 43
EP - 52
JO - British Journal of Dermatology
JF - British Journal of Dermatology
IS - SUPPL. 2
ER -
